MedPath

The Impact of SPC on Advanced Breast Cancer Patients

Completed
Conditions
Cancer, Breast
Breast Cancer
Quality of Life
Palliative Care
Interventions
Procedure: Specialist Palliative Care
Registration Number
NCT03612934
Lead Sponsor
Silesian University of Medicine
Brief Summary

The aim of this prospective, observational study is the evaluation of the effectiveness of a 14-day Specialist Palliative Care therapy in participants with advanced breast cancer carried out in a stationary palliative care unit in Poland. The length of the entire study will be 36 months.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
144
Inclusion Criteria

the patient's conscious consent for examination and the ability to fill in the form by the patient herself.

Exclusion Criteria
  • patients with cognitive disturbances disabling credible answers in the questionnaire, deceased patients or those discharged from the ward before 14 days of hospitalisation.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
patients at the age of 65 years and overSpecialist Palliative Carepatients at the age of 65 years and over
patients under the age of 65 yearsSpecialist Palliative Carepatients under the age of 65 years
Primary Outcome Measures
NameTimeMethod
Variation of performance status of patients before and after SPC14 days

performance status of patients was assessed by ECOG scale (Eastern Cooperative Oncology Group)

Variation of intensification of patients negative symptoms before and after SPC14 days

intensification of patients negative symptoms was assessed by Edmonton Symptom Assessment System (esas)

Variation of quality of life of patients before and after SPC14 days

quality of life of patients of patients was assessed by quality of life uniscale (QoLU)

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath